#BEGIN_DRUGCARD DB04191

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
144285-77-8

# ChEBI_ID:
Not Available

# Chemical_Formula:
C29H47N5O7

# Chemical_IUPAC_Name:
methyl (2S)-2-[(2S)-2-[(4S,5S)-5-[(2R)-2-[(2S)-2-aminopropanamido]propanamido]-4-hydroxy-6-phenylhexanamido]-3-methylbutanamido]-3-methylbutanoate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Skf 107457

# HET_ID:
GLI

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C29H47N5O7/c1-16(2)24(28(39)34-25(17(3)4)29(40)41-7)33-23(36)14-13-22(35)21(15-20-11-9-8-10-12-20)32-27(38)19(6)31-26(37)18(5)30/h8-12,16-19,21-22,24-25,35H,13-15,30H2,1-7H3,(H,31,37)(H,32,38)(H,33,36)(H,34,39)/t18-,19+,21-,22-,24-,25-/m0/s1

# InChI_Key:
InChIKey=IUDCAKKZLXFOQA-FDCFHUKCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4191

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
577.7128

# Molecular_Weight_Mono:
577.347548883

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1SIV

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.22

# Predicted_LogS:
-4.4

# Predicted_Water_Solubility:
2.37e-02 g/l

# Primary_Accession_No:
DB04191

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936917

# PubChem_Substance_ID:
46508521

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01606

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:04 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Y00277

# Drug_Target_1_GenBank_ID_Protein:
61731

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
gag-pol

# Drug_Target_1_Gene_Sequence:
>3171 bp
GTGTTGGAATTGTGGGAAGGAAGGACACTCTGCAAGGCAATGCAGAGCCCCAAGAAGACA
GGGATGCTGGAAATGTGGAAAAATGGACCATGTTATGGCCAAATGCCCAAACAGACAGGC
GGGTTTTTTAGGCCTTGGCCCTTGGGGAAAGAAGCCCCGCAATTTCCCCATGGCTCAAGT
GCATCAGGGGCTGACGCCAACTGCTCCCCCAGAAGAACCAGCTGTGGATCTGCTAAAGAA
CTACATGCACTTGGGCAAGCAGCAGAGAGAAAGCAGAGGGAAGCCTTACAAGGAGGTGAC
AGAGGATTTGCTGCACCTCAATTCTCTCTTTGGAGGAGACCAGTAGTCACTGCTCATATT
GAAGGACAGCCTGTAGAAGTATTATTAGATACAGGGGCTGATGATTCTATTGTAACAGGA
ATAGAGTTAGGTCCACATTATACCCCAAAAATAGTAGGAGGAATAGGAGGTTTTATTAAT
ACTAAAGAATACAAAAATGTAGAAATAGAAGTTTTAGGCAAAAGGATTAAAGGGACAATC
ATGACAGGGGACACCCCGATTAACATTTTTGGTAGAAATTTACTAACAGCTCTGGGGATG
TCTCTAAATCTTCCCATAGCTAAGGTAGAGCCTGTAAAGTCGCCCTTAAAGCCAGGAAAG
GATGGACCAAAATTGAAGCAGTGGCCATTATCAAAAGAAAAGATAGTTGCATTAAGAGAA
ATCTGTGAAAAGATGGAAAAAGATGGTCAGTTGGAGGAAGCTCCCCCGACCAATCCATAT
AACACCCCCACATTTGCTATAAAGAAAAAGGATAAAAACAAATGGAGAATGCTGATAGAT
TTTAGGGAACTAAATAGGGTCACTCAAGACTTTACGGAAGTCCAATTAGGAATACCACAC
CCTGCAGGACTAGCAAAAAGGAAAAGGATTACAGTACTGGATATAGGTGACGCATATTTC
TCTATACCTCTAGATGAAGAATTTAGGCAGTACACTGCCTTTACTTTACCATCAGTAAAT
AATGCAGAGCCAGGAAAACGATACATTTATAAGGTTCTGCCTCAGGGATGGAAGGGGTCA
CCAGCCATCTTCCAATACACTATGAGACATGTGCTAGAACCCTTCAGGAAGGCAAATCCA
GATGTGACCTTAGTCCAGTATATGGATGACATCTTAATAGCTAGTGACAGGACAGACCTG
GAACATGACAGGGTAGTTTTACAGTTAAAAGAACTCTTAAATAGCATAGGGTTTTCATCC
CCAGAAGAGAAATTCCAAAAAGATCCCCCATTTCAATGGATGGGGTACGAATTGTGGCCG
ACAAAATGGAAGTTGCAAAAGATAGAGTTGCCACAAAGAGAGACCTGGACAGTGAATGAT
ATACAGAAGTTAGTAGGAGTATTAAATTGGGCAGCTCAAATTTATCCAGGTATAAAAACC
AAACATCTCTGTAGGTTAATTAGAGGAAAAATGACTCTAACAGAGGAAGTTCAGTGGACT
GAGATGGCAGAAGCAGAATATGAGGAAAATAAAATAATTCTCAGTCAGGAACAAGAAGGA
TGTTATTACCAAGAAAGCAAGCCATTAGAAGCCACGGTGATAAAGAGTCAGGACAATCAG
TGGTCTTATAAAATTCACCAAGAAGACAAAATACTGAAAGTAGGAAAATTTGCAAAGATA
AAGAATACACATACCAATGGAGTTAGACTATTAGCACATGTAATACAGAAAATAGGAAAG
GAAGCAATAGTGATCTGGGGACAGGTCCCAAAATTCCACTTACCAGTTGAGAAGGATGTA
TGGGAACAGTGGTGGACAGACTATTGGCAGGTAACCTGGATACCGGAATGGGATTTCATC
TCAACACCACCATTAGTAAGATTAGTCTTCAATCTAGTGAAGGACCCTATAGAGGGAGAA
GAAACCTATTATGTAGATGGATCATGTAGTAAACAGTCAAAAGAAGGAAAAGCAGGATAT
ATCACAGACAGGGGCAAAGACAAGGTAAAAGTGTTAGAACAGACTACTAATCAACAAGCA
GAATTGGAAGCATTTCTCATGGCATTGACAGACTCAGGGCCAAAGGCAAATATTATAGTA
GACTCACAATATGTTATGGGAATAATAACAGGATGCCCTACAGAATCAGAGAGCAGGCTA
GTTAACCAAATAATAGAAGAAATGATCAAAAAGACAGAAATTTATGTGGCATGGGTACCA
GCACACAAAGGTATAGGAGGAAACCAAGAAATAGACCACCTAGTTAGTCAAGGGATTAGA
CAAGTTCTCTTCTTGGAAAAGATAGAGCCAGCACAAGAAGAACATAGTAAATACCATAGT
AACATAAAAGAATTGGTATTCAAATTTGGATTACCCAGACTAGTGGCCAAACAGATAGTA
GACACATGTGATAAATGTCATCAAAAAGGAGAAGCTATACATGGGCAGGTAAATTCAGAC
CTAGGGACTTGGCAAATGGATTGTACCCATCTAGAGGGAAAAATAGTCATAGTTGCAGTA
CATGTAGCTAGTGGATTCATAGAAGCAGAAGTAATTCCACAAGAAACAGGAAGACAGACA
GCACTATTTCTGTTAAAATTGGCAAGCAGATGGCCTATTACACATCTGCACACAGATAAT
GGTGCTAACTTTGCTTCGCAAGAAGTAAAGATGGTTGCATGGTGGGCAGGGATAGAGCAC
ACCTTTGGGGTACCATACAATCCACAGAGTCAGGGAGTAGTGGAAGCAATGAATCACCAC
CTGAAAAATCAAATAGATAGAATCAGGGAACAAGCAAATTCAGTAGAAACCATAGTATTA
ATGGCAGTTCATTGCATGAATTTTAAAAGAAGGGGAGGAATAGGGGATATGACTCCAGCA
GAAAGATTAATTAACATGATCACTACAGAACAAGAAATACAATTTCAACAATCAAAAAAC
TCAAAATTTAAAAATTTTCGGGTCTATTACAGAGAAGGCAGAGATCAGCTGTGGAAGGGA
CCCGGTGAGCTATTGTGGAAAGGGGAAGGAGCAGTCATCTTAAAGGTAGGAACAGACATT
AAGGTAGTACCCAGGAGAAAGGCTAAAATTATCAAAGATTATGGAGGAGGAAAAGAGATG
GATAGTAGTTCCCACATGGAGGATACCGGAGAGGCTAGAGAGGTGGCATAG

# Drug_Target_1_General_Function:
Involved in RNA binding

# Drug_Target_1_General_References:
3649576	Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, Sonigo P: Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 1987 Aug 6-12;328(6130):543-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3242

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
119744

# Drug_Target_1_Name:
Pol polyprotein

# Drug_Target_1_Number_of_Residues:
1056

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00075	RnaseH
PF00077	RVP
PF00078	RVT_1
PF00552	Integrase
PF00665	rve
PF02022	Integrase_Zn
PF06815	RVT_connect
PF06817	RVT_thumb

# Drug_Target_1_Protein_Sequence:
>Pol polyprotein [Contains: Protease
VLELWEGRTLCKAMQSPKKTGMLEMWKNGPCYGQMPKQTGGFFRPWPLGKEAPQFPHGSS
ASGADANCSPRRTSCGSAKELHALGQAAERKQREALQGGDRGFAAPQFSLWRRPVVTAHI
EGQPVEVLLDTGADDSIVTGIELGPHYTPKIVGGIGGFINTKEYKNVEIEVLGKRIKGTI
MTGDTPINIFGRNLLTALGMSLNLPIAKVEPVKSPLKPGKDGPKLKQWPLSKEKIVALRE
ICEKMEKDGQLEEAPPTNPYNTPTFAIKKKDKNKWRMLIDFRELNRVTQDFTEVQLGIPH
PAGLAKRKRITVLDIGDAYFSIPLDEEFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGS
PAIFQYTMRHVLEPFRKANPDVTLVQYMDDILIASDRTDLEHDRVVLQLKELLNSIGFSS
PEEKFQKDPPFQWMGYELWPTKWKLQKIELPQRETWTVNDIQKLVGVLNWAAQIYPGIKT
KHLCRLIRGKMTLTEEVQWTEMAEAEYEENKIILSQEQEGCYYQESKPLEATVIKSQDNQ
WSYKIHQEDKILKVGKFAKIKNTHTNGVRLLAHVIQKIGKEAIVIWGQVPKFHLPVEKDV
WEQWWTDYWQVTWIPEWDFISTPPLVRLVFNLVKDPIEGEETYYVDGSCSKQSKEGKAGY
ITDRGKDKVKVLEQTTNQQAELEAFLMALTDSGPKANIIVDSQYVMGIITGCPTESESRL
VNQIIEEMIKKTEIYVAWVPAHKGIGGNQEIDHLVSQGIRQVLFLEKIEPAQEEHSKYHS
NIKELVFKFGLPRLVAKQIVDTCDKCHQKGEAIHGQVNSDLGTWQMDCTHLEGKIVIVAV
HVASGFIEAEVIPQETGRQTALFLLKLASRWPITHLHTDNGANFASQEVKMVAWWAGIEH
TFGVPYNPQSQGVVEAMNHHLKNQIDRIREQANSVETIVLMAVHCMNFKRRGGIGDMTPA
ERLINMITTEQEIQFQQSKNSKFKNFRVYYREGRDQLWKGPGELLWKGEGAVILKVGTDI
KVVPRRKAKIIKDYGGGKEMDSSSHMEDTGEAREVA

# Drug_Target_1_Reaction:
deoxynucleoside triphosphate + DNAn = diphosphate + DNAn+1

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
During replicative cycle of retroviruses, the reverse- transcribed viral DNA is integrated into the host chromosome by the viral integrase enzyme. RNase H activity is associated with the reverse transcriptase

# Drug_Target_1_SwissProt_ID:
P05896

# Drug_Target_1_SwissProt_Name:
POL_SIVM1

# Drug_Target_1_Synonyms:
EC 2.7.7.49
EC 3.1.26.4
EC 3.4.23.-
IN]
Integrase
Pol polyprotein [Contains: Protease
RT
Retropepsin
Reverse transcriptase/ribonuclease H

# Drug_Target_1_Theoretical_pI:
8.02

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04191
